HTC finally announced a wireless VR headset, which won't be cheap.
headset to rival the Meta Quest 2. And here it is: at CES 2023, HTC revealed the HTC XR Elite, an all-in-one XR headset set for release next month. And it won't be cheap.
I wear large-framed glasses, which makes wearing certain VR headsets really uncomfortable, so I'm excited that the XR Elite has built-in diopters that adjust focus, so you can actually use the headset without glasses.
Ireland Latest News, Ireland Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Meta Fined $414 Million Over Targeted Ad PracticesMeta was fined by the E.U.'s main privacy watchdog over the way users’ data is used for personalized ads on Facebook and Instagram
Read more »
Meta hit with nearly €400mn fine over EU privacy rule violations\n\t\t\tKeep abreast of significant corporate, financial and political developments around the world.\n\t\t\tStay informed and spot emerging risks and opportunities with independent global reporting, expert\n\t\t\tcommentary and analysis you can trust.\n\t\t
Read more »
Meta fined $414m for using personal data without consentFacebook, Insta told to pay up, make changes to data slurping process within 3 months
Read more »
Meta fined €390m over use of data for targeted adsThe EU data watchdog says the way Meta obtained permission to process users' data for ads broke data law.
Read more »
Adiposity and risk of prostate cancer death: a prospective analysis in UK Biobank and meta-analysis of published studies - BMC MedicineBackground The association of adiposity with prostate cancer specific mortality remains unclear. We examined how adiposity relates to fatal prostate cancer and described the cross-sectional associations of commonly used adiposity measurements with adiposity estimated by imaging in UK Biobank. We also conducted a dose-response meta-analysis to integrate the new data with existing prospective evidence. Methods 218,237 men from UK Biobank who were free from cancer at baseline were included. Body mass index (BMI), total body fat percentage (using bioimpedance), waist circumference (WC) and waist-to-hip ratio (WHR) were collected at recruitment. Risk of dying from prostate cancer (primary cause) by the different adiposity measurements was estimated using multivariable-adjusted Cox proportional hazards models. Results from this and other prospective cohort studies were combined in a dose-response meta-analysis. Results In UK Biobank, 661 men died from prostate cancer over a mean follow-up of 11.6 years. In the subsample of participants with magnetic resonance imaging and dual-energy X-ray absorptiometry, BMI, body fat percentage and WC were strongly associated with imaging estimates of total and central adiposity (e.g. visceral fat, trunk fat). The hazard ratios (HR) for prostate cancer death were 1.07 (95% confidence interval = 0.97–1.17) per 5 kg/m2 higher BMI, 1.00 (0.94–1.08) per 5% increase in total body fat percentage, 1.06 (0.99–1.14) per 10 cm increase in WC and 1.07 (1.01–1.14) per 0.05 increase in WHR. Our meta-analyses of prospective studies included 19,633 prostate cancer deaths for BMI, 670 for body fat percentage, 3181 for WC and 1639 for WHR, and the combined HRs for dying from prostate cancer for the increments above were 1.10 (1.07–1.12), 1.03 (0.96–1.11), 1.07 (1.03–1.11), and 1.06 (1.01–1.10), respectively. Conclusion Overall, we found that men with higher total and central adiposity had similarly higher risks of prostate cancer death, which may be biol
Read more »